These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 7994779)
1. 5th International Conference on Treatment of Urinary Tract Tumors with Adriamycin/Farmorubicin. Hakone, Japan, 24-25 September 1993. Cancer Chemother Pharmacol; 1994; 35 Suppl():S1-109. PubMed ID: 7994779 [No Abstract] [Full Text] [Related]
2. The 4th International Conference on Treatment of Urinary Tract Tumors with Adriamycin/Farmorubicin. Osaka, Japan, 16-17 November 1990. Cancer Chemother Pharmacol; 1992; 30 Suppl():S1-110. PubMed ID: 1356650 [No Abstract] [Full Text] [Related]
3. [PPA (cis-platinum), peplomycin and adriamycin) combination chemotherapy in transitional cell carcinoma of the urothelial tract--pilot study]. Ono Y; Ohshima S; Fujita T; Naide Y; Suzuki K; Asoh Y; Fukushima M; Ohta K Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):28-33. PubMed ID: 2422307 [No Abstract] [Full Text] [Related]
4. Effect of recombinant human granulocyte colony-stimulating factor in patients receiving methotrexate/vinblastine/doxorubicin/cisplatin therapy for the treatment of transitional cell carcinoma of the urinary tract. Akaza H; Kotake T; Miyanaga N; Koiso K Semin Oncol; 1994 Feb; 21(1 Suppl 1):70-4. PubMed ID: 7512280 [No Abstract] [Full Text] [Related]
5. [Preoperative chemotherapy of locally disseminated cancer of the urinary bladder using methotrexate, vinblastine, platidiam and farmorubicin]. Matveev BP; Gadzhiev NG; Chevelidze ShG Urol Nefrol (Mosk); 1988; (2):38-41. PubMed ID: 3164537 [No Abstract] [Full Text] [Related]
6. [Combination chemotherapy with cisplatin, ifosfamide and adriamycin in patients with advanced transitional cell carcinoma of the urinary tract]. Yoshimoto J; Nasu Y; Akagi T; Obama T; Tsushima T; Ozaki Y; Matsumura Y; Ohmori H; Asahi T; Ohkita K Gan To Kagaku Ryoho; 1985 Jun; 12(6):1312-7. PubMed ID: 4039919 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic experience of advanced urothelial tract tumors. Nakada T; Akiya T; Yoshikawa M; Umeda K; Katayama T Hinyokika Kiyo; 1985 Apr; 31(4):601-6. PubMed ID: 4041118 [TBL] [Abstract][Full Text] [Related]
8. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. Scher HI J Urol; 1992 Nov; 148(5):1625-6. PubMed ID: 1433578 [No Abstract] [Full Text] [Related]
9. [Combination chemotherapy of cyclophosphamide, adriamycin and cisplatin in advanced urothelial cancer]. Nakagawa S; Nakao M; Toyoda K; Nukui M; Takada H; Ebisui K; Watanabe H; Furusawa T; Maegawa M; Kaiho H Gan To Kagaku Ryoho; 1987 Nov; 14(11):3071-7. PubMed ID: 3674892 [TBL] [Abstract][Full Text] [Related]
10. [Experience with combination chemotherapy consisting of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) in advanced urothelial cancer]. Nishio Y; Shirahase T; Shichiri Y; Habuchi T; Matsuda T; Nishimura K; Hida S; Okada Y; Yoshida O Hinyokika Kiyo; 1988 Aug; 34(8):1371-5. PubMed ID: 3195405 [TBL] [Abstract][Full Text] [Related]
11. [Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer--the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin]. Hinotsu S; Akaza H; Isaka S; Kagawa S; Koiso K; Kotake T; Machida T; Matsumura Y; Niijima T; Obata K; Ohashi Y; Ohe H; Shimazaki J; Tashiro K; Gan To Kagaku Ryoho; 2002 Jan; 29(1):73-80. PubMed ID: 11816482 [TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy in advanced transitional cell carcinoma of the urinary tract. Phase II trial of a combination of doxorubicin and cisplatin]. Ribrag V; Ghnassia M; Théodore C; Ghosn M; Piot G; Beurton D; Cukier J; Droz JP J Urol (Paris); 1990; 96(7):373-4. PubMed ID: 2290037 [TBL] [Abstract][Full Text] [Related]
13. Should single agents be standard therapy for urothelial tract tumors? Scher HI J Clin Oncol; 1989 Jun; 7(6):694-7. PubMed ID: 2715800 [No Abstract] [Full Text] [Related]
15. Progress in treatment of advanced urothelial tract tumors. Yagoda A J Clin Oncol; 1985 Nov; 3(11):1448-50. PubMed ID: 3903061 [No Abstract] [Full Text] [Related]
16. [Urothelial tumors of the upper urinary tract]. Boissier R; Bastien L; Lechevallier É; Meria P Rev Prat; 2014 Dec; 64(10):1408-10, 1412-4. PubMed ID: 25665325 [No Abstract] [Full Text] [Related]
17. [Comparison of effectiveness of adriamycin and epirubicin administered in the CHOP protocol to patients with malignant non-hodgkin's lymphoma]. Rolski J; Koralewski P; Pawlicki M Wiad Lek; 1993 May; 46(9-10):356-9. PubMed ID: 8236992 [TBL] [Abstract][Full Text] [Related]
18. The application of hematopoietic growth factors in advanced transitional cell carcinoma of the urinary tract. de Mulder PH; Sternberg CN; van Oosterom AT; Fossa SD Semin Oncol; 1994 Feb; 21(1 Suppl 1):65-9. PubMed ID: 7512278 [No Abstract] [Full Text] [Related]
19. A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. Logothetis CJ; Dexeus FH; Finn L; Sella A; Amato RJ; Ayala AG; Kilbourn RG J Clin Oncol; 1990 Jun; 8(6):1050-5. PubMed ID: 2189954 [TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy for advanced urothelial cancer]. Mikami K; Nakagawa S; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maegawa M; Nakao M Hinyokika Kiyo; 1994 Apr; 40(4):303-7. PubMed ID: 8191968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]